King Files 20 Levoxyl Patent Applications; Sales Up 65% to $27 Mil. In Q3

King has filed 20 patent applications for Levoxyl (levothyroxine) to extend exclusivity for the thyroid hormone product, the company said during an Oct. 29 earnings call

More from Archive

More from Pink Sheet